TZE-KIONG ER

Dr. TZE-KIONG ER

Asian University, Taichung, Taiwan
+1
orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2012 in Clinica Chimica Acta
Verified
Journal Article
Closed access
TZE-KIONG ERTZE-KIONG ER
TZE-KIONG ER
JCJan-Gowth Chang
Jan-Gowth Chang

20 February 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
CCChih-Chieh Chen
Chih-Chieh Chen
TZE-KIONG ERTZE-KIONG ER
TZE-KIONG ER
YLYen-Yi Liu
Yen-Yi Liu
JHJenn-Kang Hwang
Jenn-Kang Hwang
MBMaria Jesus Barrio
Maria Jesus Barrio
MHMarta Herreros-Villanueva
Marta Herreros-Villanueva
The issue of whether patients diagnosed with metastatic colorectal cancer who harbor KRAS codon 13 mutations could benefit from the addition of anti-epidermal growth factor receptor therapy remains under debate. The aim of the current study was to perform computational analysis to investigate the structural implications of the underlying mutations caused by c.38G>A (p.G13D) on protein conformation. Molecular dynamics (MD) simulations were performed to understand the plausible structural and dynamical implications caused by c.35G>A (p.G12D) and c.38G>A (p.G13D). The potential of mean force (PMF) simulations were carried out to determine the free energy profiles of the binding processes of GTP interacting with wild-type (WT) KRAS and its mutants (MT). Using MD simulations, we observed that the root mean square deviation (RMSD) increased as a function of time for the MT c.35G>A (p.G12D) and MT c.38G>A (p.G13D) when compared with the WT. We also observed that the GTP-binding pocket in the c.35G>A (p.G12D) mutant is more open than that of the WT and the c.38G>A (p.G13D) proteins. Intriguingly, the analysis of atomic fluctuations and free energy profiles revealed that the mutation of c.35G>A (p.G12D) may induce additional fluctuations in the sensitive sites (P-loop, switch I and II regions). Such fluctuations may promote instability in these protein regions and hamper GTP binding. Taken together with the results obtained from MD and PMF simulations, the present findings implicate fluctuations at the sensitive sites (P-loop, switch I and II regions). Our findings revealed that KRAS mutations in codon 13 have similar behavior as KRAS WT. To gain a better insight into why patients with metastatic colorectal cancer (mCRC) and the KRAS c.38G>A (p.G13D) mutation appear to benefit from anti-EGFR therapy, the role of the KRAS c.38G>A (p.G13D) mutation in mCRC needs to be further investigated.

27 February 2016 in Journal of Molecular Medicine
Verified
Journal Article
Closed access
PDF file
TZE-KIONG ERTZE-KIONG ER
TZE-KIONG ER
YSYu-Fa Su
Yu-Fa Su
CWChun-Chieh Wu
Chun-Chieh Wu
CCChih-Chieh Chen
Chih-Chieh Chen
JWJing Wang
Jing Wang
ETEing Mei Tsai
Eing Mei Tsai

1 November 2009 in Clinical Biochemistry
Verified
Journal Article
Closed access
HSHung-Chang Shih
Hung-Chang Shih
TZE-KIONG ERTZE-KIONG ER
TZE-KIONG ER
TCTien-Jye Chang
Tien-Jye Chang
YCYa-Sian Chang
Ya-Sian Chang
TLTa-Chih Liu
Ta-Chih Liu
JCJan-Gowth Chang
Jan-Gowth Chang

1 June 2019 in Clinica Chimica Acta
Verified
Journal Article
Closed access
MHM. Herreros-Villanueva
M. Herreros-Villanueva
CCChih-Chieh Chen
Chih-Chieh Chen
ETEing-Mei Tsai
Eing-Mei Tsai
TZE-KIONG ERTZE-KIONG ER
TZE-KIONG ER

8 May 2012 in Clinica Chimica Acta
Verified
Journal Article
Closed access
LHLi-Ling Hsieh
Li-Ling Hsieh
TZE-KIONG ERTZE-KIONG ER
TZE-KIONG ER
CCChih-Chieh Chen
Chih-Chieh Chen
JHJan-Sing Hsieh
Jan-Sing Hsieh
JCJan-Gowth Chang
Jan-Gowth Chang
TLTa-Chih Liu
Ta-Chih Liu